48 Polymer Nanoparticles used as Drug Carriers Characterised using NTA at Saarland University
NanoSight reports on how Nanoparticle Tracking Analysis, NTA, is used to help with the characterisation of polymeric nanoparticles synthesised as drug carrier systems. This work is being carried out at Saarland University, Saarbrücken in Germany by Dr Christian Ruge and his colleagues. In the world of pharmaceutical sciences, a detailed and full characterisation of particles synthesised as drug carrier systems is indispensable. The particle size is a crucial parameter to be monitored as this will affect the stability of formulations. It will also impact with respect to size-dependent effects in biological experiments, such as the uptake of drug systems by cells. Nanoparticle Tracking Analysis is used as a complementary tool to a Malvern Zetasizer to characterise the nanoparticles prepared by Dr Christian Ruge, a research scientist in the Department of Biopharmaceutics and Pharmaceutical Technology in the group of Professor Claus-Michael Lehr. The particles are mainly polymer-based and typically in the size range from 100nm to 400nm. Especially when studying samples of moderate polydispersity (i.e. with a polydispersity index, PDI, of larger than 0.2), the group uses the NanoSight system to measure the preparations to identify particle populations which are not resolved by the Malvern system.
Talking of the benefits of using NTA rather than techniques such as scanning electron microscopy, SEM, or dynamic light scattering, DLS, Dr Ruge commented, "The fact that the system is performing particle-by-particle-based measurements is a huge advantage, especially in terms of its resolving power. The fact that the instrument gives a concentration value is very useful. I feel that ‘visualisation’ of the particles based on their scattered light gives more ‘insight’ as to the sample and its behaviour. I personally find that it is more fun working with the NanoSight instrument compared to the Zetasizer. The interaction with the instrument and being able to visualise the individual particles makes it less of a ‘black box’ instrument and more ‘interesting’ for me as a scientist to use. Also, I have found that during demonstrations for students, the NanoSight appears to be more transparent and thus better suited for educational purposes."
MORE INFO. 139
Do you
analyse,monitor ortestfor
Mercury?
28th July - 2nd August 2013, Edinburgh, Scotland Mercury as a Global Pollutant
The 11th International Conference on Mercury as a Global Pollutant returns after 10 years to Europe in 2013.
The event will attract over 1000 international delegates and will discuss scientific advances concerning mercury in the environment.
The 2013 meeting will be of particular importance as it coincides with the United Nations Environment Programme’s legally binding global treaty on Mercury.
Registration now open, sponsorship and exhibiting opportunities available.
www.mercury2013.com Follow us: @Hg_News
High throughput end-to-end RNA-Seq Service from Beckman Coulter Genomics includes customised project design, automated Illumina TruSeq RNA-Seq library construction and flexible, multiplexed sequencing on the Illumina HiSeq platform.
Downstream bioinformatics analysis options include primary data analysis, differential gene expression, splice variant analysis, gene fusion identification and rare transcript identification.
The new automated library construction process uses Illumina TruSeq RNA sample preparation kits in conjunction with Beckman Coulter Life Sciences’ Biomek liquid handling platforms. Libraries show consistent size distribution and sequencing data is reproducible, showing good correlation with the published industry standard.
Total RNA from multiple species, including mammalian, plant and yeast samples, has been validated using the automated process. The scalable, high throughput service allows processing from one to hundreds of samples without compromising quality.
“Automated processing of RNA-Seq using the Biomek platform provides high quality data, and accommodates projects from small to large,” said Bernhard Spiess, Vice President of sales and marketing, Beckman Coulter Genomics.
“We are very pleased with this enhanced service and the ability to provide scientists with reliable, reproducible results in a timely manner.”
Technical experts in the company’s genomics services group utilise extensive experience to provide highly reliable data.
+44 (0) 1727 858840
info@mercury2013.com
Typical turnaround time is four to seven weeks after sample receipt. For more information about this service, please visit
www.beckmangenomics.com/rna-seq.
MORE INFO. 140
Automated RNA Sequencing Service Provides High Quality Results
INTERNATIONAL LABMATE - APRIL 2013
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68
